EMA Authorised: Ogluo (Glucagon) — Strongbridge Dublin Limited

View source ↗

Summary

EMA has authorised Ogluo, a glucagon medicine from Strongbridge Dublin Limited, for use in diabetes mellitus. The product is approved for emergency treatment of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• Ogluo (Glucagon)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Strongbridge Dublin Limited. Decision date: 15/09/2025